Who We Serve

Built for the people who make pharma deals and strategy calls

Three audiences, three different questions — the same disciplined research behind each answer.

Pharma & MedTech Companies

Commercial strategy grounded in what competitors are actually doing

Sales force benchmarking, brand and marketing intelligence, HCP behaviour tracking, and generic-launch readiness — so commercial decisions are made against real competitive activity, not assumptions.

Explore Competitive Intelligence

Investors & PE Firms

Diligence that stands up to an investment committee

Commercial and technical due diligence and feasibility studies for API, formulation, biosimilar and distribution targets — market sizing through NPV/IRR, typically delivered in 12 weeks.

Explore Due Diligence

Consulting Firms

Extra capacity for your own team, not a replacement for it

Primary research, expert access and data analytics that plug into your existing workstreams — scaled up or down as the engagement needs.

Explore Expert Network